Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib price?Dabrafenib mesylate when the patent is expiring in india?Guselkumab brand name?Abbvie humira patent cliff navigation success?Tenofovir generic patent?
See the DrugPatentWatch profile for trelegy
Trelegy (an inhaled COPD and asthma therapy) is made by AstraZeneca.
Trelegy is used in two common formulations: - Trelegy Ellipta (typically referenced for COPD and sometimes asthma depending on labeling) - Trelegy 100/62.5/25 mcg and Trelegy 200/62.5/25 mcg (strength variants under the Ellipta brand) AstraZeneca markets the brand.
Trelegy is a branded combination inhaler. The question of generic entry depends on the specific patents and exclusivity for each combination and strength; you can track patent-status research via DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Trelegy :